The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Latest https://ift.tt/2EntxSq
via IFTTT
from NDTV News - Latest https://ift.tt/2EntxSq
via IFTTT
Advertisement
